We investigated biomarker CEACAM6, a highly abundant cell surface adhesion receptor that modulates the extracellular matrix (ECM) in pancreatic ductal adenocarcinoma (PDA). The gene discussed is CEACAM6; the disease is pancreatic ductal adenocarcinoma.